1.6% CAGR Of Rivaroxaban Market — North America to Generate Maximum Revenue | Market.us
Pune, Maharashtra, India, September 21 2022 (Wiredrelease) Prudour Pvt. Ltd --:Global Rivaroxaban Market: Introduction Rivaroxaban is a medication used to prevent blood clots. It is also known by the brand name Xarelto. Rivaroxaban works by blocking a protein called Factor Xa. This protein is needed for your blood to clot. Rivaroxaban is used to prevent strokes and blood clots in people with atrial fibrillation (a heart rhythm disorder). It is also used to prevent deep vein thrombosis (DVT), which can lead to blood clots in the lungs (pulmonary embolism). The global rivaroxaban market size is estimated to be valued at…
- Date: September 21, 2022
- Author: Quintero
- Category: PharmiWeb